| RANBAXY | |
| Last week's close (Rs) | 1,035.35 |
| Prev. week's close (Rs) | 1,096.35 |
| Week's high (Rs) | 1,090.00 |
| Week's low (Rs) | 1,031.50 |
| Last week's ave. daily turnover (Rs cr) | 101.95 |
| Prev. week's ave. daily turnover (Rs cr) | 88.00 |
| Futures close November-2004 (Rs) | 1,038.15 |
| Futures close December-2004 (Rs) | 1,045.55 |
| Futures close January-2005 (Rs) | 1,052.00 |
| Number of up/down move | 1/3 |
| SATYAM | |
| Last week's close (Rs) | 423.48 |
| Prev. week's close (Rs) | 404.45 |
| Week's high (Rs) | 434.68 |
| Week's low (Rs) | 400.13 |
| Last week's ave. daily turnover (Rs cr) | 305.42 |
| Prev. week's ave. daily turnover (Rs cr) | 232.51 |
| Futures close November-2004 (Rs) | 422.55 |
| Futures close December-2004 (Rs) | 424.05 |
| Futures close January-2005 (Rs) | 0.00 |
| Number of up/down move | 2/2 |
| PUNJAB NATIONAL BANK | |
| Last week's close (Rs) | 320.73 |
| Prev. week's close (Rs) | 259.83 |
| Week's high (Rs) | 327.60 |
| Week's low (Rs) | 258.68 |
| Last week's ave. daily turnover (Rs cr) | 108.66 |
| Prev. week's ave. daily turnover (Rs cr) | 11.79 |
| Futures close November-2004 (Rs) | 318.95 |
| Futures close December-2004 (Rs) | 317.70 |
| Futures close January-2005 (Rs) | 315.95 |
| Number of up/down move | 4/0 |
Punjab National Bank was the biggest gainer in the Nifty last week, leading all bank scrips which had an impressive run-up at the bourses. The scrip recorded an increase of 23.4 per cent while volumes were up a whopping 808.3 per cent.
The stock of bio-technology major Biocon is likely to be in focus after the company announced plans to enter the oncology space with the launch of a new proprietary molecule Theracim by the end of the next calendar year. The company has also lined up launches of four more drugs, all of which would be anti-cancer drugs, over the next two to three years. Biocon also has plans to export Insugen to the Indian sub-continent, including Bangladesh, Sri Lanka and South East Asian countries. The company had recently announced a tie-up with US-based Nobex Corp to develop oral insulin for diabetes treatment. Also, the company recently announced that it will make an equity investment in Vaccinex, and has tied up with the US firm to develop therapeutic antibody products for cancer, inflammation and autoimmune diseases.
| |||||||||||||||||||
The behemoth of the Indian industrial sector seems to be in trouble. And it's not profits but a brewing family feud which has brought the market to the edge. Players rushed in to sell the stock as apprehensions about the Ambani brothers splitting came to light. The stock registered a fall of 3.3 per cent over last week as volumes increased 60 per cent. The scrip was showing an increasing trend over the week but fell in the last trading session. What remained rumours over the past few months suddenly became truth when Mukesh Ambani said there were differences between him and his younger brother Anil Ambani over ownership issues. Experts believe that the issue could have raised because the Late Dhirubhai Ambani did not leave a will.
| |||||||||||||||||||||||
KPIT Cummins was a gainer last week with strong buying pushing the scrip to a 52-week high on Wednesday though volumes at the counter were rather thin. The scrip, as a result, ended the week with a strong 11.7 per cent gain over its previous weekly close. Dealers say the buying in the scrip had been triggered by a strong quarterly performance and a buy call from an influential domestic broking firm. The stock had been on an ascent since the last few months and posted whopping gains of about 60 per cent since May 2004. Analysts are positive on the company's high growth practices like embedded software, SAP consulting and VLSI design where it is pumping investments in order to build a strong service practice.
| |||||||||||||||||||
The stock declined 7.52 per cent before closing the week at Rs 80.13. Tamasek Holdings, a Singapore-based investment company, acquired a 6.9 per cent in the company last week. Arnada Investment (Mauritius), a subsidiary of Tamasek, purchased 13.09 lakh shares of Satnam for Rs 73 each. The total consideration for the purchase was 9.5 crore. According to reports, a majority of these shares have been bought from the promoters of Satnam Overseas. Satnam Overseas exports basmati rice to more than 45 countries. The company also has an alliance with Punjab Agro Industries Corporation and Escorts to procure 40,000 tonnes of basmati paddy.
| |||||||||||||||||||